Potential biomarkers identified for patients with prostate cancer treated with SBRT

Researchers have identified several proteins and molecular pathways that may serve as potential biomarkers in patients with prostate cancer treated with stereotactic body radiation therapy (SBRT).

Cancer Therapy Advisor